Tvardi Therapeutics, Inc. - TVRD

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q2 2026 · Q1 2026

Value (USD)

Total reported value ($000)

$4.233M

QoQ value delta ($000)

-$4.343M (-50.64%)

Implied price effect (QoQ)

-40.13%

Total shares

2,228,805

QoQ shares delta

-474,483 (-17.55%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q2 2026 data: 57 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
Slate Path Capital LP	1,337	704,118	0.02%
VANGUARD CAPITAL MANAGEMENT LLC	654	344,382	0.0%
AMERICAN FINANCIAL GROUP INC	424	223,659	0.15%
UBS Group AG	211	111,133	0.0%
SILVERCREST ASSET MANAGEMENT GROUP LLC	191	101,034	0.0%
BlackRock, Inc.	181	95,478	0.0%
RENAISSANCE TECHNOLOGIES LLC	173	91,409	0.0%
GEODE CAPITAL MANAGEMENT, LLC	171	90,350	0.0%
MORGAN STANLEY	147	77,845	0.0%
Duncan Williams Asset Management, LLC	120	63,241	0.03%
VANGUARD FIDUCIARY TRUST CO	84	44,710	0.0%
Russell Investments Group, Ltd.	82	43,228	0.0%
STATE STREET CORP	64	33,900	0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	63	33,165	0.0%
AQR CAPITAL MANAGEMENT LLC	51	27,096	0.0%
Savant Capital, LLC	49	19,462	0.0%
NORTHERN TRUST CORP	41	21,836	0.0%
GSA CAPITAL PARTNERS LLP	34	17,885	0.0%
DIADEMA PARTNERS LP	31	16,607	0.0%
XTX Topco Ltd	28	14,868	0.0%
BROWN ADVISORY INC	21	11,200	0.0%
Arax Advisory Partners	20	11,003	0.0%
Qube Research & Technologies Ltd	19	10,210	0.0%
Persistent Asset Partners Ltd	8	4,253	0.0%
PNC FINANCIAL SERVICES GROUP, INC.	6	3,518	0.0%